📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nivalis

1.1 - Company Overview

Nivalis Logo

Nivalis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage pharmaceutical therapies designed to preserve intracellular S-nitrosoglutathione (GSNO), an endogenous molecule with cell signaling effects implicated in cystic fibrosis pathophysiology; developing a novel class of disease-modifying treatments, including lead candidate N91115 initially targeting CF patients.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nivalis

Primrose Therapeutics Logo

Primrose Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on creating treatments for polycystic kidney disease (PKD), a life-threatening genetic disorder affecting 600,000 Americans and 12.5 million people worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Primrose Therapeutics company profile →
Cydan Logo

Cydan

HQ: United States Website
  • Description: Provider of orphan drug accelerator services focused on identifying and de-risking compounds with therapeutic and commercial potential.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cydan company profile →
Soin Therapeutics Logo

Soin Therapeutics

HQ: United States Website
  • Description: Provider of pharmaceutical drug development focused on new medications for rare, orphan diseases, including a novel formulation of low-dose naltrexone to treat CRPS.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Soin Therapeutics company profile →
BioElectron Logo

BioElectron

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioElectron company profile →
HemoShear Logo

HemoShear

HQ: United States Website
  • Description: Provider of the REVEAL-Tx platform, a drug discovery system combining biological and computational models to accelerate development of treatments for rare disorders. Offerings include HST5040, a clinical candidate for Propionic Acidemia and Methylmalonic Acidemia, and a human tissue-based model of rare liver disease developed in collaboration with Takeda.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HemoShear company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nivalis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nivalis

2.2 - Growth funds investing in similar companies to Nivalis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nivalis

4.2 - Public trading comparable groups for Nivalis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nivalis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nivalis

What does Nivalis do?

Nivalis is a provider of clinical-stage pharmaceutical therapies designed to preserve intracellular S-nitrosoglutathione (GSNO), an endogenous molecule with cell signaling effects implicated in cystic fibrosis pathophysiology; developing a novel class of disease-modifying treatments, including lead candidate N91115 initially targeting CF patients.

Who are Nivalis's competitors?

Nivalis's competitors and similar companies include Primrose Therapeutics, Cydan, Soin Therapeutics, BioElectron, and HemoShear.

Where is Nivalis headquartered?

Nivalis is headquartered in United States.

How many employees does Nivalis have?

Nivalis has 1,000 employees 🔒.

When was Nivalis founded?

Nivalis was founded in 2010 🔒.

What sector and industry vertical is Nivalis in?

Nivalis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nivalis

Who are the top strategic acquirers in Nivalis's sector and industry

Top strategic M&A buyers and acquirers in Nivalis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nivalis?

Top strategic M&A buyers groups and sectors for Nivalis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nivalis's sector and industry vertical

Which are the top PE firms investing in Nivalis's sector and industry vertical?

Top PE firms investing in Nivalis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nivalis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nivalis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nivalis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nivalis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nivalis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nivalis?

The key public trading comparables and valuation benchmarks for Nivalis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nivalis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nivalis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nivalis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nivalis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nivalis's' sector and industry vertical?

Access recent funding rounds and capital raises in Nivalis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nivalis

Launch login modal Launch register modal